计算血液形成可塑性,以应对遗传突变和环境刺激
Yuchen Wen1,2,3, Hang He1,2,3, Yunxi Ma1,2,3
1National Key Laboratory of Experimental Hematology, Tianjin, China.
Life science alliance
|November 13, 2024
概括
细胞可塑性,一个动态的细胞状态,对于组织修复至关重要. 一个新的管道,scPlasticity,揭示了在Tet2突变或炎症后,造血干细胞的细胞可塑性增加.
科学领域:
- 细胞生物学 细胞生物学
- 血液形成 血液形成 血液形成
- 系统生物学 系统生物学
背景情况:
- 细胞可塑性 (CP) 对于再生和修复等生物过程至关重要.
- 单细胞欧米克数据为分析CP提供了强大的工具.
- 血液形成为开发定量CP分析方法提供了一个模型系统.
研究的目的:
- 开发和验证一个计算管道,scPlasticity,用于分析造血干细胞和祖细胞 (HSPC) 的可塑性.
- 调查突变 (Tet2) 和环境 (DSS) 挑战对HSPC可塑性的影响.
- 为了确定改变HSPC可塑性的关键分子调节剂.
主要方法:
- 生成高质量的血统负的单细胞RNA测序数据集.
- 使用UMAP或FA进行数据可视化和分析的scPlasticity管道的应用.
- 在 silico 扰动实验中评估基因/通路淘汰的影响.
主要成果:
- 在野生类型细胞中观察到血液构造发育的连续性,在过渡轨道上混合细胞 (CP) 的比例较低.
- Tet2突变和DSS治疗显著增加了HSPC中的CP,表明增强了可塑性.
- 几种转录因子和信号通路 (例如EGR,IL-1R1,β-上腺受体) 被确定为CP变化的关键调节者.
结论:
- 该 scPlasticity 管道有效量化细胞在造血干细胞和祖细胞的细胞可塑性.
- Tet2突变和炎症增强HSPC的可塑性,这表明在疾病发病过程中发挥了作用.
- 针对EGR,IL-1R1或β上腺受体等特定途径可能提供治疗策略,以调节疾病状态中的CP.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Overview of Hematopoiesis
3.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.8K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K


